Buscar

Mostrando ítems 1-10 de 105

Traces of immunoediting during myeloproliferative neoplasm to secondary acute myeloid leukemia transition

Pretti, Marco Antônio; Barros, Luciana Carvalho; Ayres, Jackline; Scherer, Nicole; Daumas, Adelmo; Solza, Cristiana; Braggio, Esteban; Renault, Ilana Zalcberg; Boroni, Mariana; Bonamino, Martín Hernán (Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2018)

Philadelphia-negative chronic myeloproliferative neoplasms

Bittencourt, Rosane Isabel; Vassallo, Jose; Chauffaille, Maria de Lourdes Lopes Ferrari [UNIFESP]; Xavier, Sandra Guerra; Pagnano, Katia Borgia; Nascimento, Ana Clara Kneese; De Souza, Carmino Antonio; Chiattone, Carlos Sergio (Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2012-01-01)

Chronic myeloproliferative diseases without the Philadelphia chromosome marker (Ph-), although first described 60 years ago, only became the subject of interest after the turn of the millennium. In 2001, the World Health ...

The prevalence of CALR mutations in a cohort of patients with myeloproliferative neoplasms

Grinsztejn, Eduarda; Percy, M. J.; McClenaghan, D.; Quintana, M.; Cuthbert, R. J. G.; McMullin, M. F. (2018)

Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation

Cacemiro, Maira da Costa; Cominal, Juçara Gastaldi; Ribeiro, Raquel Tognon; Nunes, Natalia de Souza; Simões, Belinda Pinto; Pontes, Lorena Lôbo de Figueiredo; Catto, Luiz Fernando Bazzo; Traina, Fabíola; Souto, Elizabeth Xisto; Zambuzi, Fabiana Albani; Frantz, Fabiani Gai; Castro, Fabíola Attié de (-Brasil-, 2018)

Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation

Cacemiro, Maira da Costa; Cominal, Juçara Gastaldi; Tognon, Raquel; Nunes, Natalia de Souza; Simões, Belinda Pinto; Figueiredo-Pontes, Lorena Lôbo de; Catto, Luiz Fernando Bazzo; Traina, Fabíola; Souto, Elizabeth Xisto; Zambuzi, Fabiana Albani; Frantz, Fabiani Gai; Castro, Fabíola Attié de (-Brasil-, 2019)

Whole exome sequencing of philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative disorders (MDS/MPD)

Hosp Israelita Albert Einstein; HEMOMED; Hosp Brigadeiro; Ctr Hematol Sao Paulo; Hosp Leforte; Hosp Mario Covas; Univ Fed Rio Grande do Norte; Fundacao Hosp Amaral Carvalho; Universidade Estadual Paulista (Unesp); Clin Oncol Integrada; Universidade Federal da Bahia (UFBA); Universidade Federal de Goiás (UFG); Universidade Estadual de Campinas (UNICAMP) (Amer Soc Hematology, 2014-12-06)

Incidence and impact of activating mutations of the RAS-RAF- MEK-ERK pathway in patients with philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative disorders-unclassified (MDS/MPD-U)

Hosp Israelita Albert Einstein; HEMOMED; Hosp Brigadeiro; Ctr Hematol Sao Paulo; Hosp Leforte; Hosp Mario Covas; Fundacao Hosp Amaral Carvalho; Univ Fed Rio Grande do Norte; Universidade Estadual Paulista (Unesp); Clin Oncol Integrada; Universidade Federal da Bahia (UFBA); Universidade Federal de Goiás (UFG) (Amer Soc Hematology, 2014-12-06)

Platelets as mediators of Thromboinflammation in chronic Myeloproliferative Neoplasms

Marin Oyarzún, Cecilia Paola; Heller, Paula Graciela (Frontiers Research Foundation, 2019-06-14)

Chronic myeloproliferative neoplasms (MPN) are stem cell disorders driven by mutations in JAK2, CALR, or MPL genes and characterized by myeloid proliferation and increased blood cell counts. They encompass three closely ...

Philadelphia-negative chronic myeloproliferative neoplasms

Bittencourt, Rosane Isabel; Vassallo, Jose; Chauffaille, Maria de Lourdes Lopes Ferrari; Xavier, Sandra Guerra; Pagnano, Katia Borgia; Nascimento, Ana Clara Kneese; De Souza, Carmino Antonio; Chiattone, Carlos Sergio (Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2012)

Irs2 Silencing Increases Apoptosis And Potentiates The Effects Of Ruxolitinib In Jak2v617f-positive Myeloproliferative Neoplasms.

de Melo Campos, Paula; Machado-Neto, João A; Eide, Christopher A; Savage, Samantha L; Scopim-Ribeiro, Renata; Duarte, Adriana da Silva Souza; Favaro, Patricia; Lorand-Metze, Irene; Costa, Fernando F; Tognon, Cristina E; Druker, Brian J; Olalla Saad, Sara T; Traina, Fabiola (2016)

1
2
3
4
. . .
11

Buscar

Filtros

Traces of immunoediting during myeloproliferative neoplasm to secondary acute myeloid leukemia transition

Philadelphia-negative chronic myeloproliferative neoplasms

The prevalence of CALR mutations in a cohort of patients with myeloproliferative neoplasms

Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation

Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation

Whole exome sequencing of philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative disorders (MDS/MPD)

Incidence and impact of activating mutations of the RAS-RAF- MEK-ERK pathway in patients with philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative disorders-unclassified (MDS/MPD-U)

Platelets as mediators of Thromboinflammation in chronic Myeloproliferative Neoplasms

Philadelphia-negative chronic myeloproliferative neoplasms

Irs2 Silencing Increases Apoptosis And Potentiates The Effects Of Ruxolitinib In Jak2v617f-positive Myeloproliferative Neoplasms.